IP Library Granted Patent US 11,504,408
Granted Patent B2
US 11,504,408 · App. 16/976,952 · Granted Nov 22, 2022

Fasting-mimicking diet (FMD) but not water-only fasting promotes reversal of inflammation and IBD pathology

Inventors: Valter D. Longo (Playa Del Rey, CA); Min Wei (West Covina, CA); Priya Rangan (Los Angeles, CA)
Assignee: University of Southern California
A61K35/747A23L3/44A23L33/135A61K9/16A61K9/48A61K35/745A61K45/06A61K2035/115
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,504,408
App. No.
16/976,952
Granted
Nov 22, 2022
Kind
B2
Abstract

A method for treating autoimmune and/or inflammatory disease includes a step of identifying a subject exhibiting symptoms of autoimmune and/or inflammatory disease administering a fasting mimicking diet. A probiotic composition for gastrointestinal autoimmune and/or inflammatory disease Bacteroides acidifaciens, Bifidobacterium choerinum , and combinations thereof is also provided.

Claims (17)

1. A probiotic composition for gastrointestinal autoimmune and/or inflammatory disease, the probiotic composition comprising:

a bacterial component that is a combination of Bacteroides acidifaciens and Bifidobacterium choerinum such that the Bifidobacterium choerinum enhances probiotic activity of Bacteroides acidifaciens to be administered for prevention and treatment of gastrointestinal autoimmune and/or inflammatory disease; and

a protective component that stabilizes the bacterial component.

2. The probiotic composition of claim 1 wherein the bacterial component further comprises gut microbiota strains isolated from genera selected from the group consisting of Lactobacillus, Allobaculum, Bifidobacterium , and combinations thereof.

3. The probiotic composition of claim 2 wherein each bacterial component is present in an amount from about 10 3 to about 10 14 CFU/g of each bacterial component.

4. The probiotic composition of claim 1 wherein the protective component is selected from the group consisting of protective carriers, protective coating, and protective encapsulants.

5. The probiotic composition of claim 1 wherein the protective component is a liquid.

6. The probiotic composition of claim 5 wherein the liquid is a hydroxylated hydrocarbon carrier.

7. The probiotic composition of claim 5 wherein the liquid is a polyol.

8. The probiotic composition of claim 1 wherein the protective component includes a stabilization agent that interacts with or encapsulates the bacterial component.

9. The probiotic composition of claim 8 wherein the stabilization agent is selected from the group consisting of adonitol, betaine, carbohydrates, proteins, amino acids, mixtures of sugar and protein, gums and skim milk, and combinations thereof.

10. The probiotic composition of claim 9 wherein the stabilization agent is dissolved or dispersed in a liquid.

11. The probiotic composition of claim 1 wherein the protective component encapsulates the bacterial component.

12. The probiotic composition of claim 11 wherein the bacterial component is encapsulated by spray drying, fluidized bed drying, or vacuum drying.

13. The probiotic composition of claim 11 wherein the protective component includes an encapsulating agent selected from the group consisting of maltodextrins, skim milk, reconstituted skim milk, casein, soybean protein, trehalose, and combinations thereof.

14. The probiotic composition of claim 1 further comprising an additive selected from the group consisting of any suitable adjuvants, excipients, additives, additional therapeutic agents, bioavailability enhancers, side-effect suppressing components, diluents, buffers, flavoring agents, binders, preservatives or other ingredients and combinations thereof.

15. The probiotic composition of claim 1 incorporated into a capsule.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2020
From: LONGO, VALTER D.; WEI, MIN; RANGAN, PRIYA
To: UNIVERSITY OF SOUTHERN CALIFORNIA
Reel/Frame 053653/0858 →
Continuity (4)
Provisional Application 62735147 · Sep 23, 2018
Provisional Application 62734475 · Sep 21, 2018
Provisional Application 62643296 · Mar 15, 2018
Related Publication 20200390833A1 · Dec 17, 2020